Status | Study |
RECRUITING |
Study Name: Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) Condition: Rett Syndrome Date: 2023-11-21 Interventions: TSHA-102 is a recombinant, non-replicating, self-complementary AAV9 (scAAV9) vector encoding for the miniMECP2 gene.TSHA-102 is a one-time intra |
RECRUITING |
Study Name: Neurophysiologic Biomarkers in Rett Syndrome Condition: Rett Syndrome Date: 2023-06-27 Interventions: Through up to seven standardized sessions, participants will undergo AEP and VEP, as well as resting state EEG. |
RECRUITING |
Study Name: A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome Condition: Date: 2023-06-01 Interventions: NGN-401 is a non-replicating, recombinant AAV9 carrying a full length human MECP2 transgene. |
RECRUITING |
Study Name: A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome Condition: Rett Syndrome Date: 2023-06-01 Interventions: NGN-401 is a non-replicating, recombinant AAV9 carrying a full length human MECP2 transgene. |
Completed |
Study Name: Osteopathic Manipulative Treatment for Constipation in People With Rett Syndrome Condition: Rett Syndrome Date: 2022-12-30 Interventions: Interventional |
Active, not recruiting |
Study Name: Intensive Anti-Scoliosis Postural Intervention for Individuals With Rett Syndrome Supported by a Smartphone Application Condition: Rett Syndrome Date: 2022-08-01 Interventions: Intensive Anti-Scoliosis Postural Intervention for Individuals With Rett Syndrome Supported by a Smartphone Application |
Completed |
Study Name: Tolerability of the Immersive Virtual Reality System Grail in Subjects Affected by Rett Syndrome Condition: Rett Syndrome Date: 2022-05-26 Interventions: Interventional |
Not yet recruiting |
Study Name: Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome. Condition: Rett Syndrome Date: 2017-02-02 Interventions: Drug: Tridecanoic Acid 3 times daily oral doze of the drug for 20 weeks with 4 weeks of baseline and 4 w |
Completed |
Study Name: A Safety Study of NNZ-2566 in Pediatric Rett Syndrome Condition: Rett Syndrome Date: 2016-02-21 Interventions: Drug: NNZ-2566 Glycyl-L-2-Meth |
Active, not recruiting |
Study Name: An Exploratory Trial of Ketamine for the Treatment of Rett Syndrome Condition: Rett Syndrome Date: 2015-09-28 Interventions: Procedure: Intravenous infusion |